Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.51 |
| ▸ | CTSK | P43235 | 6/20 | 0.50 |
| ▸ | CTSS | P25774 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL918952 | 1.00 | FOLH1 (0.53) | FOLH1ITGB3ITGA2BCTSKCTSS | |
| SCHEMBL376450 | 1.00 | FOLH1 (0.53) | FOLH1ITGB3ITGA2BCTSKCTSS | |
| Hydrochloric Acid SCHEMBL28376761 | 0.98 | FOLH1 (0.51) | FOLH1ITGB3ITGA2BCTSKCTSS | |
| SCHEMBL6751878 | 0.98 | FOLH1 (0.51) | FOLH1ITGB3ITGA2BCTSKCTSS | |
| Hydrochloric Acid SCHEMBL919653 | 0.98 | FOLH1 (0.51) | FOLH1ITGB3ITGA2BCTSKCTSS | |
| Hydrochloric Acid SCHEMBL1711148 | 0.98 | FOLH1 (0.51) | FOLH1ITGB3ITGA2BCTSKCTSS | |
| SCHEMBL30395713 | 0.98 | FOLH1 (0.51) | FOLH1ITGB3ITGA2BCTSKCTSS | |
| Acetic Acid SCHEMBL15812253 | 0.97 | FOLH1 (0.50) | FOLH1ITGB3ITGA2BCTSKCTSS | |
| SCHEMBL205184 | 0.95 | CTSK (0.51) | FOLH1ITGB3ITGA2BCTSKCTSS | |
| SCHEMBL1487792 | 0.95 | CTSK (0.51) | FOLH1ITGB3ITGA2BCTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1760 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138944-A1 | METHOD FOR PREPARING FMOC-LYS(IVDDE)-OH | SICHUAN SHIFANG SANGAO BIOCHEMICAL INDUSTRIAL CO., LTD. (CN) | 2026-05-21 | — | — | US | claimed |
| EP-4737434-A2 | METHOD FOR PREPARING FMOC-LYS(IVDDE)-OH | Sichuan Shifang Sangao Biochemical Industrial Co., Ltd. (CN) | 2026-05-06 | — | — | EP | claimed |
| EP-3943599-B1 | AMINOACYL-TRNA SYNTHETASE FOR EFFICIENTLY INTRODUCING LYSINE DERIVATIVE IN PROTEIN | NINGBO KUNPENG BIOTECH CO LTD (CN) | 2025-10-01 | — | — | EP | claimed |
| WO-2025128649-A1 | A TRANSLATION-INDEPENDENT DIRECTED EVOLUTION STRATEGY TO ENGINEER AMINOACYL-TRNA SYNTHETASES | TRUSTEES OF BOSTON COLLEGE (US) | 2025-06-19 | — | — | WO | claimed |
| CN-120082044-A | Hyaluronic acid main chain polylysine side chain brush polymer and preparation method and application thereof | 苏州大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119818698-A | Micro-molecular drug conjugate based on anisoamide targeted human prostate cancer cells, preparation method and application thereof | 华东师范大学 | 2025-04-15 | — | — | CN | claimed |
| CN-119798363-A | Preparation and application of dendritic lipopeptide molecule | 中国药科大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119751310-A | Preparation method of Fmoc-Lys (IVdde) -OH | 四川什邡市三高生化实业有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119708124-A | Liquid phase synthesis method of bursin tripeptide | 厦门胜泽泰医药科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| WO-2025056976-A1 | STABLE HIGH TITER VECTOR PACKAGING SUSPENSION CELL LINES | VIROCELL BIOLOGICS LTD (GB) | 2025-03-20 | — | — | WO | claimed |
| EP-0866080-B1 | Mouldings with anticoagulant properties, their preparation and their use in the manufacturing of articles useful in medical fields | VESTOLIT GMBH & CO KG (DE) | 2002-07-31 | — | — | EP | claimed |
| EP-0709373-B1 | PYRROLIDINE DERIVATIVE | ZAIDAN HOJIN BISEIBUTSU (JP) | 2001-10-17 | — | — | EP | claimed |
| US-6160056-A | Molding materials having anticoagulant properties, their preparation and processing to give articles which are used in medical technology | VESTOLIT GMBH (DE) | 2000-12-12 | — | — | US | claimed |
| CN-1265670-A | Dipeptides and related compounds that inhibit VLA-4 mediated leukocyte adhesion | ELAND PHARMACEUTICALS CO (US) | 2000-09-06 | — | — | CN | claimed |
| EP-0866080-A2 | Mouldings with anticoagulant properties, their preparation and their use in the manufacturing of articles useful in medical fields | Vestolit GmbH (DE) | 1998-09-23 | — | — | EP | claimed |
| EP-0861857-A2 | Mouldings with anticoagulant properties, their preparation and their use in the manufacturing of articles usefull in medical fields | Vestolit GmbH (DE) | 1998-09-02 | — | — | EP | claimed |
| EP-0590038-A4 | AMINO ACID DERIVATIVE AND BROMOACETYL MODIFIED PEPTIDES | US HEALTH (US) | 1994-08-24 | — | — | EP | claimed |
| WO-1992022318-A1 | AMINO ACID DERIVATIVE AND BROMOACETYL MODIFIED PEPTIDES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the DEPARTEMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-12-23 | — | — | WO | claimed |
| EP-0090100-B1 | INSOLUBLE POLYMERS WITH ANTI-COAGULATING PROPERTIES, ARTICLES CONTAINING THEM AND METHODS OF MANUFACTURE | Fougnot, Christine (FR) | 1986-09-17 | — | — | EP | claimed |
| EP-0023854-B1 | SOLUBLE POLYMERS POSSESSING ANTICOAGULATING PROPERTIES, PROCESS FOR PREPARING THEM AND THEIR USE AS DRUGS WITH ANTICOAGULATING ACTION | Fougnot, Christine (FR) | 1984-12-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138944-A1 | METHOD FOR PREPARING FMOC-LYS(IVDDE)-OH | ALAD, BCKDK, OGDH | FOLH1 1652/4885ITGB3 1561/4885ITGA2B 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.